George Blanck

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 48

Top Topics

Multiple Myeloma

Top Venues

Cell cycle (Georgetown, Tex.)

Viral immunology

JCO precision oncology

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

George Angelakakis, Mallika Varkhedi, Toriana R Dabkowski, Michael J Diaz, Michelle Yeagley, George Blanck
B-cell ALL with SOX11 gene amplification associates with a worse outcome. Cell cycle (Georgetown, Tex.) (2024)
George Angelakakis, Mallika Varkhedi, Toriana R Dabkowski, Michael J Diaz, Michelle Yeagley, George Blanck
B-cell ALL with SOX11 gene amplification associates with a worse outcome. Cell cycle (Georgetown, Tex.) 23 (1) (2024)
Rahul Jain, Max Bressler, Andrea Chobrutskiy, Boris I Chobrutskiy, George Blanck
High-throughput quantitative assessments of the chemical complementarity of celiac disease related IGH CDR3s and a gliadin epitope. International immunology (2024)
Tabitha R Hudock, Joanna J Song, Andrea Chobrutskiy, Boris I Chobrutskiy, George Blanck
IGH Complementarity Determining Region-3-Cytomegalovirus Protein Chemical Complementarity Linked to Better Overall Survival Probabilities for Glioblastoma. Viral immunology 37 (5) (2024)
Tabitha R Hudock, Joanna J Song, Andrea Chobrutskiy, Boris I Chobrutskiy, George Blanck
IGH Complementarity Determining Region-3-Cytomegalovirus Protein Chemical Complementarity Linked to Better Overall Survival Probabilities for Glioblastoma. Viral immunology 37 (5) (2024)
George Angelakakis, Mallika Varkhedi, Toriana R Dabkowski, Michael J Diaz, Michelle Yeagley, George Blanck
B-cell ALL with SOX11 gene amplification associates with a worse outcome. Cell cycle (Georgetown, Tex.) 23 (1) (2024)
Rahul Jain, Max Bressler, Andrea Chobrutskiy, Boris I Chobrutskiy, George Blanck
High-throughput quantitative assessments of the chemical complementarity of celiac disease-related IGH CDR3s and a gliadin epitope. International immunology 36 (9) (2024)
Tabitha R Hudock, Joanna J Song, Andrea Chobrutskiy, Boris I Chobrutskiy, George Blanck
IGH Complementarity Determining Region-3-Cytomegalovirus Protein Chemical Complementarity Linked to Better Overall Survival Probabilities for Glioblastoma. Viral immunology (2024)
George Angelakakis, Mallika Varkhedi, Toriana R Dabkowski, Michael J Diaz, Michelle Yeagley, George Blanck
B-cell ALL with SOX11 gene amplification associates with a worse outcome. Cell cycle (Georgetown, Tex.) 23 (1) (2024)
Tabitha R Hudock, Joanna J Song, Andrea Chobrutskiy, Boris I Chobrutskiy, George Blanck
IGH Complementarity Determining Region-3-Cytomegalovirus Protein Chemical Complementarity Linked to Better Overall Survival Probabilities for Glioblastoma. Viral immunology (2024)
George Angelakakis, Mallika Varkhedi, Toriana R Dabkowski, Michael J Diaz, Michelle Yeagley, George Blanck
B-cell ALL with SOX11 gene amplification associates with a worse outcome. Cell cycle (Georgetown, Tex.) 23 (1) (2024)
Tabitha R Hudock, Joanna J Song, Andrea Chobrutskiy, Boris I Chobrutskiy, George Blanck
IGH Complementarity Determining Region-3-Cytomegalovirus Protein Chemical Complementarity Linked to Better Overall Survival Probabilities for Glioblastoma. Viral immunology 37 (5) (2024)
George Angelakakis, Mallika Varkhedi, Toriana R Dabkowski, Michael J Diaz, Michelle Yeagley, George Blanck
B-cell ALL with SOX11 gene amplification associates with a worse outcome. Cell cycle (Georgetown, Tex.) 23 (1) (2024)
Hope J Wolmarans, Vayda R Barker, Andrea Chobrutskiy, Boris I Chobrutskiy, Taha I Huda, George Blanck
Exploiting big data survival information to unify risk-stratification related, adaptive immune receptor parameters for multiple myeloma. Genes and immunity (2023)
Nagehan Pakasticali, Andrea Chobrutskiy, Dhruv N Patel, Monica Hsiang, Saif Zaman, Konrad J Cios, George Blanck, Boris I Chobrutskiy
Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression. Cancer informatics 22 (2023)
Joanna J Song, Andrea Chobrutskiy, Boris I Chobrutskiy, Konrad J Cios, Taha I Huda, Rachel A Eakins, Michael J Diaz, George Blanck
Chemical Complementarity of Tumor Resident, Adaptive Immune Receptor CDR3s and Previously Defined Hepatitis C Virus Epitopes Correlates with Improved Outcomes in Hepatocellular Carcinoma. Viral immunology (2023)
Kennedy W Mwangi, Moses K Kamita, Jacqueline W Waweru, Shahin Sayed, Jonine D Figueroa, Stefan Ambs, Konrad J Cios, George Blanck, Francis W Makokha
Adaptive immune receptor features related to breast cancer tissue in Kenyan patients: high immunoglobulin gene expression and high levels of gamma-delta T-cells. Breast cancer research and treatment (2023)
Toriana R Dabkowski, Mallika Varkhedi, Joanna J Song, Etienne C Gozlan, George Blanck
Neuroblastoma and Glioblastoma Cases With Amplified Oncogenes Have Reduced Numbers of Tumor-Resident Adaptive Immune Receptor Recombinations. JCO precision oncology 7 (2023)
Michael J Diaz, Dorottya B Kacsoh, Dhruv N Patel, Michelle Yeagley, Monica Hsiang, George Blanck
Tumor resident, TRA anti-viral CDR3 chemical sequence motifs are associated with a better breast cancer outcome. Genes and immunity (2023)
Jessica U Quach, Michael J Diaz, Taha I Huda, Jacob C Kinskey, Saif Zaman, John E Desantis, Konrad J Cios, George Blanck
Bacterial Sequencing Reads in Blood Exome Files from Melanoma and Cervical Cancer Patients are Associated with Cancer Recurrence. Molecular biotechnology (2023)
Jacob C Kinskey, Taha I Huda, Etienne C Gozlan, Jessica U Quach, Juan F Arturo, Andrea Chobrutskiy, Boris I Chobrutskiy, George Blanck
The presence of intratumoral Porphyromonas gingivalis correlates with a previously defined pancreatic adenocarcinoma, immune cell expression phenotype and with tumor resident, adaptive immune receptor features. Carcinogenesis (2023)
Toriana R Dabkowski, Mallika Varkhedi, Joanna J Song, Etienne C Gozlan, George Blanck
Neuroblastoma and Glioblastoma Cases With Amplified Oncogenes Have Reduced Numbers of Tumor-Resident Adaptive Immune Receptor Recombinations. JCO precision oncology 7 (2023)
Toriana R Dabkowski, Mallika Varkhedi, Joanna J Song, Etienne C Gozlan, George Blanck
Neuroblastoma and Glioblastoma Cases With Amplified Oncogenes Have Reduced Numbers of Tumor-Resident Adaptive Immune Receptor Recombinations. JCO precision oncology 7 (2023)
Joanna J Song, Andrea Chobrutskiy, Boris I Chobrutskiy, Konrad J Cios, Taha I Huda, Rachel A Eakins, Michael J Diaz, George Blanck
TRB CDR3 chemical complementarity with HBV epitopes correlates with increased hepatocellular carcinoma, disease-free survival. Journal of medical virology 95 (8) (2023)
Anishaa R Patel, Dhruv N Patel, Yaping N Tu, Michelle Yeagley, Andrea Chobrutskiy, Boris I Chobrutskiy, George Blanck
Chemical complementarity between immune receptor CDR3s and candidate cancer antigens correlating with reduced survival: evidence for outcome mitigation with corticosteroid treatments. Journal of biomolecular structure & dynamics (2022)
Etienne C Gozlan, Boris I Chobrutskiy, George Blanck
Exploiting adaptive immune receptor recombination read recoveries from exome files to identify subsets of ALL and to establish TCR features that correlate with better outcomes. International journal of laboratory hematology 44 (5) (2022)
Konrad J Cios, Taha I Huda, Rachel A Eakins, Moody M Mihyu, George Blanck
Specific TCR V-J gene segment recombinations leading to the identification pan-V-J CDR3s associated with survival distinctions: diffuse large B-cell lymphoma. Leukemia & lymphoma 63 (6) (2022)
Taha I Huda, Moody Mihyu, Etienne C Gozlan, Mary F Arndt, Michael J Diaz, Saif Zaman, Boris I Chobrutskiy, George Blanck
Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival rates. Leukemia & lymphoma 62 (7) (2021)
Michelle Yeagley, Boris I Chobrutskiy, Etienne C Gozlan, Nikhila Medikonda, Dhruv N Patel, Shayan Falasiri, Blake M Callahan, Taha Huda, George Blanck
Electrostatic Complementarity of T-Cell Receptor-Alpha CDR3 Domains and Mutant Amino Acids Is Associated with Better Survival Rates for Sarcomas. Pediatric hematology and oncology 38 (3) (2021)
Etienne C Gozlan, Boris I Chobrutskiy, Saif Zaman, Michelle Yeagley, George Blanck
Systemic Adaptive Immune Parameters Associated with Neuroblastoma Outcomes: the Significance of Gamma-Delta T Cells. Journal of molecular neuroscience : MN 71 (11) (2021)
Boris I Chobrutskiy, Michelle Yeagley, Andrea Diviney, Saif Zaman, Etienne C Gozlan, Price Tipping, Darush M Koohestani, Andrea M Roca, George Blanck
A scoring system for the electrostatic complementarities of T-cell receptors and cancer-mutant amino acids: multi-cancer analyses of associated survival rates. Immunology 159 (4) (2020)
Andrea Chobrutskiy, Boris I Chobrutskiy, Saif Zaman, Monica Hsiang, George Blanck
Chemical features of blood-borne TRG CDR3s associated with an increased overall survival in breast cancer. Breast cancer research and treatment 185 (3) (2020)
Boris I Chobrutskiy, Michelle Yeagley, Price Tipping, Saif Zaman, Andrea Diviney, Dhruv N Patel, Shayan Falasiri, Vladimir N Uversky, George Blanck
Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma. Oncogene 39 (8) (2019)
Blake M Callahan, Wei Lue Tong, George Blanck
T cell receptor-β J usage, in combination with particular HLA class II alleles, correlates with better cancer survival rates. Immunologic research 66 (2) (2019)
Andrea Diviney, Boris I Chobrutskiy, Saif Zaman, George Blanck
An age-based, RNA expression paradigm for survival biomarker identification for pediatric neuroblastoma and acute lymphoblastic leukemia. Cancer cell international 19 (2019)
Juan F Arturo, Boris I Chobrutskiy, Michelle Yeagley, Dhruv N Patel, Shayan Falasiri, Jay S Patel, George Blanck
Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates. Cellular & molecular immunology 17 (7) (2019)
Saif Zaman, Boris I Chobrutskiy, Jay S Patel, Blake M Callahan, Moody M Mihyu, Andrea Diviney, George Blanck
Potential MMP2-mediated availability of HLA binding, mutant ECM peptides reflects better melanoma survival rates and greater T-cell infiltrates. Laboratory investigation; a journal of technical methods and pathology 99 (9) (2019)
Yaping N Tu, Wei Lue Tong, John M Yavorski, George Blanck
Immunogenomics: A Negative Prostate Cancer Outcome Associated with TcR-γ/δ Recombinations. Cancer microenvironment : official journal of the International Cancer Microenvironment Society 11 (1) (2018)
Boris I Chobrutskiy, Saif Zaman, Wei Lue Tong, Andrea Diviney, George Blanck
Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade. Journal of neuro-oncology 140 (3) (2018)
Kendall R Clark, Wei Lue Tong, Blake M Callahan, John M Yavorski, Yaping N Tu, George Blanck
TRB-J1 usage, in combination with the HLA-A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltrates. International journal of immunogenetics 46 (1) (2018)
Wei Lue Tong, Blake M Callahan, Yaping N Tu, Saif Zaman, Boris I Chobrutskiy, George Blanck
Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates. Breast cancer research and treatment 173 (1) (2018)
Jacob C Kinskey, Yaping N Tu, Wei Lue Tong, John M Yavorski, George Blanck
Recovery of Immunoglobulin VJ Recombinations from Pancreatic Cancer Exome Files Strongly Correlates with Reduced Survival. Cancer microenvironment : official journal of the International Cancer Microenvironment Society 11 (1) (2018)
Dhiraj Sikaria, Yaping N Tu, Diana A Fisler, James A Mauro, George Blanck
Identification of specific feed-forward apoptosis mechanisms and associated higher survival rates for low grade glioma and lung squamous cell carcinoma. Journal of cancer research and clinical oncology 144 (3) (2018)
Blake M Callahan, John M Yavorski, Yaping N Tu, Wei Lue Tong, Jacob C Kinskey, Kendall R Clark, Timothy J Fawcett, George Blanck
T-cell receptor-β V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns. Cancer immunology, immunotherapy : CII 67 (6) (2018)
Boris I Chobrutskiy, Saif Zaman, Andrea Diviney, Moody M Mihyu, George Blanck
T-cell receptor-α CDR3 domain chemical features correlate with survival rates in bladder cancer. Journal of cancer research and clinical oncology 145 (3) (2018)
Yaping N Tu, Wei Lue Tong, Mohammad D Samy, John M Yavorski, Minjung Kim, George Blanck
Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-α/β V(D)J recombinations correlates with PD-1 expression. International journal of cancer 140 (11) (2017)
Nicolette M Clark, Carlos A Garcia Galindo, Vandan K Patel, Michele L Parry, Rebecca J Stoll, John M Yavorski, Elizabeth P Pinkason, Edna M Johnson, Chelsea M Walker, Joseph Johnson, Wade J Sexton, Domenico Coppola, George Blanck
The human, F-actin-based cytoskeleton as a mutagen sensor. Cancer cell international 17 (2017)
Blake M Callahan, Jay S Patel, Timothy J Fawcett, George Blanck
Cytoskeleton and ECM tumor mutant peptides: Increased protease sensitivities and potential consequences for the HLA class I mutant epitope reservoir. International journal of cancer 142 (5) (2017)